Stockchizumab is currently self-funded at $1188 per injection, self-funded injections at the recommended dose will cost $35,640 a year, the actual cost is based on the actual price of the local hospital, the actual injection dose. Stockchizumab injection is mostly used in the clinic for moderate and severe plaque psoriasis, there may be rhinitis, nasopharyngitis, diarrhea, conjunctivitis and other adverse reactions, allergic to the drug, children, pregnant and lactating women are prohibited. Skuclizumab injection entered the medical insurance, the current out-of-pocket expenses per 1188 yuan. Currently, according to the recommended therapeutic dose of 300mg each time, the initial administration of subcutaneous injection at weeks 0, 1, 2, 3 and 4, and then maintain the dose every 4 weeks, you need about 30 injections a year, a total of 35,640 yuan, and can be further reimbursed on a sliding scale if you have health insurance. During the actual treatment, the doctor may adjust the dosage at his/her discretion according to the patient’s own situation, and it is recommended to refer to the actual price and the actual injection dosage in the local hospital.